Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Revekka Harisi & Andras Jeney. (2015) Extracellular matrix as target for antitumor therapy. OncoTargets and Therapy 8, pages 1387-1398.
Read now
Read now
Seunghee Yoon & Rony Seger. (2006) The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24:1, pages 21-44.
Read now
Read now
Paul Shapiro. (2002) Ras-MAP Kinase Signaling Pathways and Control of Cell Proliferation: Relevance to Cancer Therapy. Critical Reviews in Clinical Laboratory Sciences 39:4-5, pages 285-330.
Read now
Read now
Articles from other publishers (76)
Kathryn Balmanno, Andrew M. Kidger, Dominic P. Byrne, Matthew J. Sale, Nejma Nassman, Patrick A. Eyers & Simon J. Cook. (2023) ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. Biochemical Journal 480:9, pages 587-605.
Crossref
Crossref
Vishal Singh, Tayyaba Afshan, Pankaj Tyagi, Pritish Kumar Varadwaj & Amaresh Kumar Sahoo. (2023) Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics. International Journal of Biological Macromolecules 226, pages 473-484.
Crossref
Crossref
Zhen Wang, Weixue Huang, Kaijie Zhou, Xiaomei Ren & Ke Ding. (2022) Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery?. Journal of Medicinal Chemistry 65:3, pages 1735-1748.
Crossref
Crossref
Vid Mlakar, Edouard Morel, Simona Jurkovic Mlakar, Marc Ansari & Fabienne Gumy-Pause. (2021) A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Ashley C. Dougherty, Mariam G. Hawaz, Kristine G. Hoang, Judy Trac, Jacob M. Keck, Carmen Ayes & Joseph E. Deweese. (2021) Exploration of the Role of the C-Terminal Domain of Human DNA Topoisomerase IIα in Catalytic Activity. ACS Omega 6:40, pages 25892-25903.
Crossref
Crossref
Pui-Kei Wu, Andrew Becker & Jong-In Park. (2020) Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway. International Journal of Molecular Sciences 21:15, pages 5436.
Crossref
Crossref
Andrew M. Kidger, Joanne M. Munck, Harpreet K. Saini, Kathryn Balmanno, Emma Minihane, Aurelie Courtin, Brent Graham, Marc O'Reilly, Richard Odle & Simon J. Cook. (2020) Dual-Mechanism ERK1/2 Inhibitors Exploit a Distinct Binding Mode to Block Phosphorylation and Nuclear Accumulation of ERK1/2. Molecular Cancer Therapeutics 19:2, pages 525-539.
Crossref
Crossref
Rachel M. Sammons & Kevin N. Dalby. 2020. Next Generation Kinase Inhibitors. Next Generation Kinase Inhibitors
109
139
.
Francesco Marampon, Carmela Ciccarelli & Bianca Maria Zani. (2019) Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation. International Journal of Molecular Sciences 20:10, pages 2530.
Crossref
Crossref
Andrew M. Kidger, James Sipthorp & Simon J. Cook. (2018) ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. Pharmacology & Therapeutics 187, pages 45-60.
Crossref
Crossref
Seung-Keun Hong, Pui-Kei Wu & Jong-In Park. (2018) A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses. Cellular Signalling 42, pages 11-20.
Crossref
Crossref
Asaf Shvero, Ohad Hilly, Golan Bubis, Yaniv Hamzany, Rumelia Koren & Lea Rath‑Wolfson. (2017) Expression of Topoisomerase II‑α protein in salivary gland tumors. Molecular and Clinical Oncology.
Crossref
Crossref
Jennifer E. Kung & Natalia Jura. (2016) Structural Basis for the Non-catalytic Functions of Protein Kinases. Structure 24:1, pages 7-24.
Crossref
Crossref
Vincent Panneton, Apurba Nath, Fadi Sader, Nathalie Delaunay, Ariane Pelletier, Dominic Maier, Karen Oh & David R. Hipfner. (2015) Regulation of Catalytic and Non-catalytic Functions of the Drosophila Ste20 Kinase Slik by Activation Segment Phosphorylation. Journal of Biological Chemistry 290:34, pages 20960-20971.
Crossref
Crossref
T Chen, Y Sun, P Ji, S Kopetz & W Zhang. (2014) Topoisomerase IIα in chromosome instability and personalized cancer therapy. Oncogene 34:31, pages 4019-4031.
Crossref
Crossref
Tsung-Ming Lee, Shinn-Zong Lin & Nen-Chung Chang. (2014) Antiarrhythmic effect of lithium in rats after myocardial infarction by activation of Nrf2/HO-1 signaling. Free Radical Biology and Medicine 77, pages 71-81.
Crossref
Crossref
N A Bonito, J Drechsler, S Stoecker, C R Carmo, M J Seckl, H M Hermanns & A P Costa-Pereira. (2013) Control of gp130 expression by the mitogen-activated protein kinase ERK2. Oncogene 33:17, pages 2255-2263.
Crossref
Crossref
Jong-In Park. (2014) Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Frontiers in Biology 9:2, pages 95-103.
Crossref
Crossref
Friedrich Wartlick, Anita Bopp, Christian Henninger & Gerhard Fritz. (2013) DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:12, pages 3093-3103.
Crossref
Crossref
Min-Hyuk Yoo, Bradley A. Carlson, Vadim N. Gladyshev & Dolph L. Hatfield. (2013) Abrogated Thioredoxin System Causes Increased Sensitivity to TNF-α-Induced Apoptosis via Enrichment of p-ERK 1/2 in the Nucleus. PLoS ONE 8:9, pages e71427.
Crossref
Crossref
Hiroyuki Tamaichi, Masaki Sato, Andrew C. G. Porter, Toshiaki Shimizu, Shuki Mizutani & Masatoshi Takagi. (2013) Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor. Cancer Science 104:2, pages 178-184.
Crossref
Crossref
Michael A. Morgan, Fredrick O. Onono, H. Peter Spielmann, Thangaiah Subramanian, Michaela Scherr, Letizia Venturini, Iris Dallmann, Arnold Ganser & Christoph W. M. Reuter. (2011) Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells. Journal of Molecular Medicine 90:2, pages 149-161.
Crossref
Crossref
Seychelle M. Vos, Elsa M. Tretter, Bryan H. Schmidt & James M. Berger. (2011) All tangled up: how cells direct, manage and exploit topoisomerase function. Nature Reviews Molecular Cell Biology 12:12, pages 827-841.
Crossref
Crossref
Jessica Ponder, Byong Hoon Yoo, Adedoyin D. Abraham, Qun Li, Amanda K. Ashley, Courtney L. Amerin, Qiong Zhou, Brian G. Reid, Philip Reigan, Robert Hromas, Jac A. Nickoloff & Daniel V. LaBarbera. (2011) Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition. Marine Drugs 9:11, pages 2397-2408.
Crossref
Crossref
Javier RodríguezPiero Crespo. (2011) Working Without Kinase Activity: Phosphotransfer-Independent Functions of Extracellular Signal–Regulated Kinases. Science Signaling 4:196.
Crossref
Crossref
Alexander Plotnikov, Eldar Zehorai, Shiri Procaccia & Rony Seger. (2011) The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:9, pages 1619-1633.
Crossref
Crossref
Bojie Dai, X. Frank Zhao, Krystyna Mazan-Mamczarz, Patrick Hagner, Sharon Corl, El Mustapha Bahassi, Song Lu, Peter J. Stambrook, Paul Shapiro & Ronald B. Gartenhaus. (2011) Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma. Nature Communications 2:1.
Crossref
Crossref
Christopher RunchelAtsushi MatsuzawaHidenori Ichijo. (2011) Mitogen-Activated Protein Kinases in Mammalian Oxidative Stress Responses. Antioxidants & Redox Signaling 15:1, pages 205-218.
Crossref
Crossref
Kimberly A. Burkhard, Fengming Chen & Paul Shapiro. (2011) Quantitative Analysis of ERK2 Interactions with Substrate Proteins. Journal of Biological Chemistry 286:4, pages 2477-2485.
Crossref
Crossref
Mei-Chuan Chen, Chun-Han Chen, Hsiao-Ching Chuang, Samuel K. Kulp, Che-Ming Teng & Ching-Shih Chen. (2011) Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells. Hepatology 53:1, pages 148-159.
Crossref
Crossref
Javier Rodríguez, Fernando Calvo, José M. González, Berta Casar, Vicente Andrés & Piero Crespo. (2010) ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma–lamin A complexes. Journal of Cell Biology 191:5, pages 967-979.
Crossref
Crossref
Eldar Zehorai, Zhong Yao, Alexander Plotnikov & Rony Seger. (2010) The subcellular localization of MEK and ERK—A novel nuclear translocation signal (NTS) paves a way to the nucleus. Molecular and Cellular Endocrinology 314:2, pages 213-220.
Crossref
Crossref
Seung-Keun Hong, Seunghee Yoon, Cas Moelling, Dumrongkiet Arthan & Jong-In Park. (2009) Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling. Journal of Biological Chemistry 284:48, pages 33006-33018.
Crossref
Crossref
Zhong Yao & Rony Seger. (2009) The ERK signaling cascade-Views from different subcellular compartments. BioFactors 35:5, pages 407-416.
Crossref
Crossref
Alan Coss, Miriam Tosetto, Edward J. Fox, Beata Sapetto-Rebow, Sheeona Gorman, Breandán N. Kennedy, Andrew T. Lloyd, John M. Hyland, Diarmuid P. O’Donoghue, Kieran Sheahan, Dermot T. Leahy, Hugh E. Mulcahy & Jacintha N. O’Sullivan. (2009) Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. Cancer Letters 276:2, pages 228-238.
Crossref
Crossref
E. A. Williamson, K. K. Rasila, L. K. Corwin, J. Wray, B. D. Beck, V. Severns, C. Mobarak, S.-H. Lee, J. A. Nickoloff & R. Hromas. (2008) The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation. Nucleic Acids Research 36:18, pages 5822-5831.
Crossref
Crossref
Hongchang Li, Yun Wang & Xiaoqi Liu. (2008) Plk1-dependent Phosphorylation Regulates Functions of DNA Topoisomerase IIα in Cell Cycle Progression. Journal of Biological Chemistry 283:10, pages 6209-6221.
Crossref
Crossref
Chung-Pei Lee, Jen-Yang Chen, Jiin-Tarng Wang, Keiji Kimura, Ai Takemoto, Chih-Chung Lu & Mei-Ru Chen. (2007) Epstein-Barr Virus BGLF4 Kinase Induces Premature Chromosome Condensation through Activation of Condensin and Topoisomerase II. Journal of Virology 81:10, pages 5166-5180.
Crossref
Crossref
Michael L.H. Wong, Andrew H. Kaye & Christopher M. Hovens. (2007) Targeting malignant glioma survival signalling to improve clinical outcomes. Journal of Clinical Neuroscience 14:4, pages 301-308.
Crossref
Crossref
Timothy N. Feinstein & Adam D. Linstedt. (2007)
Mitogen-activated Protein Kinase Kinase 1-dependent Golgi Unlinking Occurs in G
2
Phase and Promotes the G
2
/M Cell Cycle Transition
. Molecular Biology of the Cell 18:2, pages 594-604.
Crossref
Crossref
Malka Cohen-Armon, Leonid Visochek, Dana Rozensal, Adi Kalal, Ilona Geistrikh, Rodika Klein, Sarit Bendetz-Nezer, Zhong Yao & Rony Seger. (2007) DNA-Independent PARP-1 Activation by Phosphorylated ERK2 Increases Elk1 Activity: A Link to Histone Acetylation. Molecular Cell 25:2, pages 297-308.
Crossref
Crossref
Mio Shinohara, Alexei V. Mikhailov, Julio A. Aguirre-Ghiso & Conly L. Rieder. (2006)
Extracellular Signal-regulated Kinase 1/2 Activity Is Not Required in Mammalian Cells during Late G
2
for Timely Entry into or Exit from Mitosis
. Molecular Biology of the Cell 17:12, pages 5227-5240.
Crossref
Crossref
Fengming Chen, Chad N. Hancock, Alba T. Macias, Joseph Joh, Kimberly Still, Shijun Zhong, Alexander D. MacKerellJr.Jr. & Paul Shapiro. (2006) Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure. Bioorganic & Medicinal Chemistry Letters 16:24, pages 6281-6287.
Crossref
Crossref
Aarati Ranganathan, Mustafa N. Yazicioglu & Melanie H. Cobb. (2006) The Nuclear Localization of ERK2 Occurs by Mechanisms Both Independent of and Dependent on Energy. Journal of Biological Chemistry 281:23, pages 15645-15652.
Crossref
Crossref
Catherine R. Barker, Nathalie A.P. Mouchel & John R. Jenkins. (2006) The identification and characterisation of a functional interaction between arginyl-tRNA-protein transferase and topoisomerase II. Biochemical and Biophysical Research Communications 342:2, pages 596-604.
Crossref
Crossref
Rada Philipova, Mark G. Larman, Calum P. Leckie, Patrick K. Harrison, Laurence Groigno & Michael Whitaker. (2005) Inhibiting MAP Kinase Activity Prevents Calcium Transients and Mitosis Entry in Early Sea Urchin Embryos. Journal of Biological Chemistry 280:26, pages 24957-24967.
Crossref
Crossref
Chad N. Hancock, Alba Macias, Eun Kyoung Lee, Su Yeon Yu, Alexander D. MacKerell, & Paul Shapiro. (2005) Identification of Novel Extracellular Signal-Regulated Kinase Docking Domain Inhibitors. Journal of Medicinal Chemistry 48:14, pages 4586-4595.
Crossref
Crossref
Chad N. Hancock, Surabhi Dangi & Paul Shapiro. (2005) Protein Phosphatase 2A Activity Associated with Golgi Membranes during the G2/M Phase May Regulate Phosphorylation of ERK2. Journal of Biological Chemistry 280:12, pages 11590-11598.
Crossref
Crossref
Muktadir S. Hossain, Kenji Kurokawa, Nobuyoshi Akimitsu & Kazuhisa Sekimizu. (2004)
DNA topoisomerase II is required for the G
0
-to-S phase transition in
Drosophila
Schneider cells, but not in yeast
. Genes to Cells 9:10, pages 905-917.
Crossref
Crossref
Jae Hyung Koo, Stephanie Gill, Lewis K. Pannell, Bert Ph. M. Menco, Joyce W. Margolis & Frank L. Margolis. (2004) The interaction of Bex and OMP reveals a dimer of OMP with a short half-life. Journal of Neurochemistry 90:1, pages 102-116.
Crossref
Crossref
Angelique W. Whitehurst, Fred L. Robinson, Mary Shannon Moore & Melanie H. Cobb. (2004) The Death Effector Domain Protein PEA-15 Prevents Nuclear Entry of ERK2 by Inhibiting Required Interactions. Journal of Biological Chemistry 279:13, pages 12840-12847.
Crossref
Crossref
Anthony K.F Liou, Robert S Clark, David C Henshall, Xiao-Ming Yin & Jun Chen. (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Progress in Neurobiology 69:2, pages 103-142.
Crossref
Crossref
Isabelle Plo, Hélène Hernandez, Glenda Kohlhagen, Dominique Lautier, Yves Pommier & Guy Laurent. (2002) Overexpression of the Atypical Protein Kinase C ζ Reduces Topoisomerase II Catalytic Activity, Cleavable Complexes Formation, and Drug-induced Cytotoxicity in Monocytic U937 Leukemia Cells. Journal of Biological Chemistry 277:35, pages 31407-31415.
Crossref
Crossref
Angelique W. Whitehurst, Julie L. Wilsbacher, Youngjai You, Kate Luby-Phelps, Mary Shannon Moore & Melanie H. Cobb. (2002) ERK2 enters the nucleus by a carrier-independent mechanism. Proceedings of the National Academy of Sciences 99:11, pages 7496-7501.
Crossref
Crossref
James A. Fagin. (2002) Minireview: Branded from the Start—Distinct Oncogenic Initiating Events May Determine Tumor Fate in the Thyroid. Molecular Endocrinology 16:5, pages 903-911.
Crossref
Crossref
JT Lee Jr & JA McCubrey. (2002) The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16:4, pages 486-507.
Crossref
Crossref
Udo Kellner, Maxwell Sehested, Peter B Jensen, Frank Gieseler & Pierre Rudolph. (2002) Culprit and victim – DNA topoisomerase II. The Lancet Oncology 3:4, pages 235-243.
Crossref
Crossref
Michelle Sabourin & Neil Osheroff. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
Hyukjin Cha, Eun Kyoung Lee & Paul Shapiro. (2001) Identification of a C-terminal Region That Regulates Mitogen-activated Protein Kinase Kinase-1 Cytoplasmic Localization and ERK Activation. Journal of Biological Chemistry 276:51, pages 48494-48501.
Crossref
Crossref
Alexandre E. Escargueil, Sergei Y. Plisov, Andrzej Skladanowski, Annie Borgne, Laurent Meijer, Gary J. Gorbsky & Annette K. Larsen. (2001) Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling. The FASEB Journal 15:12, pages 1-22.
Crossref
Crossref
Francis S. Willard & Michael F. Crouch. (2001) MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells. Cellular Signalling 13:9, pages 653-664.
Crossref
Crossref
Zhu Chen, Tara Beers Gibson, Fred Robinson, Loraine Silvestro, Gray Pearson, Bing-e Xu, Angelique Wright, Colleen Vanderbilt & Melanie H. Cobb. (2001) MAP Kinases. Chemical Reviews 101:8, pages 2449-2476.
Crossref
Crossref
Véronique Cruciani, Trine Husøy & Svein-Ole Mikalsen. (2001) Pharmacological Evidence for System-Dependent Involvement of Protein Kinase C Isoenzymes in Phorbol Ester-Suppressed Gap Junctional Communication. Experimental Cell Research 268:2, pages 150-161.
Crossref
Crossref
Daoud Meerzaman, Paul S. Shapiro & K. Chul Kim. (2001) Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 281:1, pages L86-L91.
Crossref
Crossref
Hyukjin Cha & Paul Shapiro. (2001) Tyrosine-Phosphorylated Extracellular Signal–Regulated Kinase Associates with the Golgi Complex during G2/M Phase of the Cell Cycle. Journal of Cell Biology 153:7, pages 1355-1368.
Crossref
Crossref
Gray Pearson, Fred Robinson, Tara Beers Gibson, Bing-e Xu, Mahesh Karandikar, Kevin Berman & Melanie H. Cobb. (2001) Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*. Endocrine Reviews 22:2, pages 153-183.
Crossref
Crossref
Michael A. MorganOliver DolpChristoph W. M. Reuter. (2001) Cell-cycle–dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling. Blood 97:6, pages 1823-1834.
Crossref
Crossref
A. Jane Bardwell, Laura J. Flatauer, Karen Matsukuma, Jeremy Thorner & Lee Bardwell. (2001) A Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and Cooperates with a Scaffold Protein to Enhance Signal Transmission. Journal of Biological Chemistry 276:13, pages 10374-10386.
Crossref
Crossref
Andrew N. Hoofnagle, Katheryn A. Resing, Elizabeth J. Goldsmith & Natalie G. Ahn. (2001) Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. Proceedings of the National Academy of Sciences 98:3, pages 956-961.
Crossref
Crossref
Mark J. Gemkow, Joachim Dichter & Donna J. Arndt-Jovin. (2001) Developmental Regulation of DNA-Topoisomerases during Drosophila Embryogenesis. Experimental Cell Research 262:2, pages 114-121.
Crossref
Crossref
Shih-Chang Tsai, Nikola Valkov, Wen-Ming Yang, Jana Gump, Daniel Sullivan & Edward Seto. (2000) Histone deacetylase interacts directly with DNA topoisomerase II. Nature Genetics 26:3, pages 349-353.
Crossref
Crossref
Harold I Saavedra, Jeffrey A Knauf, Jill M Shirokawa, Jianwei Wang, Bin Ouyang, Rosella Elisei, Peter J Stambrook & James A Fagin. (2000) The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene 19:34, pages 3948-3954.
Crossref
Crossref
Deborah Fox & A.George Smulian. (2000) Mkp1 of Pneumocystis carinii associates with the yeast transcription factor Rlm1 via a mechanism independent of the activation state. Cellular Signalling 12:6, pages 381-390.
Crossref
Crossref
Harold I. Saavedra, Kenji Fukasawa, Christopher W. Conn & Peter J. Stambrook. (1999) MAPK Mediates RAS-induced Chromosome Instability. Journal of Biological Chemistry 274:53, pages 38083-38090.
Crossref
Crossref
William T. Beck, Susan E. Morgan, Yin-Yuan Mo & Uppoor G. Bhat. (1999) Tumor cell resistance to DNA topoisomerase II inhibitors: new developments. Drug Resistance Updates 2:6, pages 382-389.
Crossref
Crossref
Alan J. Whitmarsh & Roger J. Davis. (1999) Signal Transduction by MAP Kinases: Regulation by Phosphorylation-Dependent Switches. Science's STKE 1999:1.
Crossref
Crossref